Metastatic Colon Cancer Clinical Trials

33 clinical trials for Metastatic Colon Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer — RECRUITING · PHASE1
• Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer — RECRUITING · PHASE3
• Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial — RECRUITING · NA
• Liver Embolization Approaches for Tumor Management — RECRUITING
• A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer — NOT_YET_RECRUITING · PHASE3
• A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer — TERMINATED · PHASE2
• Curcumin in Combination With 5FU for Colon Cancer — TERMINATED · PHASE1
• CALM: Managing Distress in Malignant Brain Cancer — COMPLETED · NA
• xDRIVE in Metastatic Colorectal Cancer — NOT_YET_RECRUITING
• Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients — ACTIVE_NOT_RECRUITING · NA
• A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer — COMPLETED · PHASE3
• Development of Clinical and Biological Database in Colorectal Cancer — COMPLETED · NA
• Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer — WITHDRAWN · PHASE1
• ZETA : Prospective Observational Study — COMPLETED
• REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients — COMPLETED · NA
• A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers — COMPLETED · PHASE1
• Pembrolizumab + Poly-ICLC in MRP Colon Cancer — COMPLETED · PHASE1
• PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer — OTHER · NA
• Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial — COMPLETED · PHASE2
• A Study to Assess PV-10 Chemoablation of Cancer of the Liver — OTHER · PHASE1
• Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer — OTHER
• Hepatic Artery Infusion (HAI) Program at Duke University — WITHDRAWN · NA
• SGM-101 in Colorectal Lung Metastases — OTHER · PHASE2
• A Study of ASN007 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer — OTHER · PHASE3
• Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors — COMPLETED · NA
• Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients — COMPLETED · PHASE1
• Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers — TERMINATED
• Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer — OTHER · PHASE2
• Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors — WITHDRAWN · NA
• Study of Skin Toxicity of Cetuximab: Find a Link Between Skin Inflammation and Tumor Response — COMPLETED · PHASE2
• A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients — OTHER · PHASE2

Refine this search